| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.12B | 990.40M | 981.70M | 989.50M | 672.40M | 256.30M |
| Gross Profit | 1.11B | 951.40M | 963.70M | 934.70M | 656.80M | 246.00M |
| EBITDA | 756.80M | 548.30M | 598.70M | 637.10M | 585.30M | 124.50M |
| Net Income | 596.00M | 451.20M | 473.40M | 526.80M | 457.10M | 108.90M |
Balance Sheet | ||||||
| Total Assets | 9.95B | 9.34B | 9.12B | 8.87B | 7.46B | 7.02B |
| Cash, Cash Equivalents and Short-Term Investments | 1.25B | 604.80M | 990.00M | 761.50M | 296.90M | 947.90M |
| Total Debt | 6.97B | 6.11B | 6.13B | 6.02B | 5.20B | 1.93B |
| Total Liabilities | 7.34B | 6.85B | 6.82B | 6.87B | 5.84B | 5.71B |
| Stockholders Equity | 2.61B | 2.49B | 2.30B | 1.97B | 1.62B | 1.31B |
Cash Flow | ||||||
| Free Cash Flow | 33.40M | 129.50M | 246.40M | 235.60M | 100.20M | 290.80M |
| Operating Cash Flow | 33.80M | 136.10M | 255.90M | 243.40M | 111.00M | 300.90M |
| Investing Cash Flow | 814.50M | 276.10M | 71.50M | 45.50M | 64.70M | -74.00M |
| Financing Cash Flow | -425.70M | -524.60M | -282.50M | 111.30M | -653.30M | 471.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £24.82B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
77 Outperform | £3.38B | 9.24 | 6.50% | 7.21% | -7.11% | 0.45% | |
76 Outperform | £8.91B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.35B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
54 Neutral | £2.02B | 110.86 | 4.25% | 2.85% | 62.91% | -15.13% | |
52 Neutral | £6.45B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |